BD Recognized for its Patient Safety Solutions with Frost & Sullivan’s 2017 Visionary Innovation Leadership Award
Becton, Dickinson and Company (BD) is a leading med-tech company that has continuously partnered with customers and stakeholders to address the most pressing needs of patient safety across a variety of care settings. BD’s impressive product portfolio, end-to-end integrated technology platforms, efficient data management, and global distribution channels facilitate significant synergies that lead to tangible cost and efficiency savings. This enables the company to partner with its customers to improve patient safety in key areas of medication management, antibiotic resistance, sepsis, and HAI prevention.
No other company in the industry offers as many solutions in this space. Frost & Sullivan research confirms that BD’s portfolio and capabilities provide the company with significant synergistic benefits for healthcare institutions and for their patients. These synergies allow BD to offer unmatched cost savings and efficiency improvements to healthcare providers, thus positioning the company as a preferred choice for implementing its customers’ patient safety initiatives.
Frost & Sullivan firmly believes that BD’s broad portfolio of products and solutions specifically aimed at improving patient safety across a variety of adverse events uniquely positions the company as a visionary leader in the domain. — Anuj Agarwal | Senior Research Analyst | Frost & Sullivan